Pharmacology & ToxicologybioRxivPreprint
Targeting GPR183 to reduce peripheral sensitization: evidence from rodent and human tissue analyses
Kyle Oberkrom, Kathryn Braden, Evelyn Li…·Daniela Salvemini
This study identifies GPR183 as a driver of peripheral sensitization in rodents and humans, showing its role in pain pathways through immune cell activation and highlighting its potential as a therapeutic target.